Soluble Guanylate Cyclase ␣ 1 and ␤ 1 Gene Transfer Increases NO Responsiveness and Reduces Neointima Formation After Balloon Injury in Rats via Antiproliferative
and Antimigratory Effects R estenosis after successful balloon angioplasty of obstructed coronary arteries is caused by vessel recoil and neointima formation 1 due to increased smooth muscle cell (SMC) migration and proliferation, extracellular matrix production, 2 and platelet and leukocyte activation. NO/cGMP signal transduction plays an important role in normal vascular homeostasis and in the vascular response to injury. NO is produced in endothelial cells by a constitutive NO synthase (NOS3) and regulates many functions of vascular cells and circulating platelets and leukocytes. 3 NO is also synthesized by the inducible NOS isoform (NOS2), which is expressed on stimulation of endothelial cells, SMCs, and macrophages with lipopolysaccharide and/or cytokine. 3 NO interacts with several intracellular molecular targets, one of which is soluble guanylate cyclase (sGC), a heterodimer consisting of ␣ and ␤ subunits linked by disulphide bonds. 4 Two isoforms of each subunit have been identified in the rat, and the heterodimer formed by the ␣ 1 and ␤ 1 subunits has been detected in many tissues and cell types, including vascular SMCs. 5, 6 Binding of NO to the heme group in sGC stimulates conversion of GTP to cGMP, 7 the intracellular second messenger that mediates the vasodilator capacity of NO. 8 NO and cGMP also modulate other vascular cell functions, including cellular proliferation, apoptosis, migration, and extracellular matrix production. 9 -14 Local 15 or systemic 16 administration of NO donors and local transfer of genes encoding NOS 17, 18 can attenuate neointima formation after vascular balloon injury. However, it is not clear whether NO attenuates neointima formation via a direct, cGMP-mediated effect on medial and neointimal SMCs, via a cGMP-independent effect on vascular cells, or indirectly by blocking adhesion of circulating blood elements and the release of growth factors from these cells. Therefore, we investigated the regulation of NO/cGMP signal transduction in vascular SMCs of the balloon-injured vessel wall and the effect of modulating sGC function in these cells by adenoviral gene transfer. Adenoviruses specifying sGC ␣ 1 and ␤ 1 subunits were constructed, and the effect of sGC overexpression on SMC function and neointima formation after balloon injury in the presence or absence of low concentrations of an NO donor was studied.
We observed that arterial balloon injury reduced sGC levels and enzyme activity in medial SMCs. Coinfection of injured carotid arteries with recombinant adenoviruses specifying the sGC ␣ 1 and ␤ 1 subunits enabled low doses of molsidomine to increase arterial cGMP levels and to inhibit neointima formation. Thus, NO can reduce the neointimal response to injury via a direct, cGMP-dependent effect on vascular SMCs. Moreover, the ability to transduce vascular cells in vivo with 2 different viral vectors offers important new prospects for cardiovascular gene therapy.
Materials and Methods

Recombinant Adenoviruses
Ad␣1, Ad␤1, AdLacZ, AdGFP, and AdRR5 are E1-deleted replication-defective adenoviruses. Ad␣1 contains the cDNA encoding the 82-kDa ␣ 1 subunit of rat sGC with sequences encoding the 8-amino acid FLAG epitope "tag" 19 ligated in-frame at the 5Ј end of the ␣ 1 subunit cDNA. Ad␤1 contains the cDNA encoding the 70-kDa ␤ 1 subunit of rat sGC with sequences encoding the c-myc epitope tag 20 ligated in-frame at the 5Ј end of the ␤ 1 subunit cDNA. AdRR5 is a control adenovirus expressing no transgene. 21 AdLacZ carries the LacZ gene encoding a nuclear-localizing variant of Escherichia coli ␤-galactosidase, and AdGFP (kindly provided by Dr A. Rosenzweig, Massachusetts General Hospital, Charlestown, Mass) expresses the cDNA encoding green fluorescent protein. Intracellular cGMP concentrations in RASMCs infected with AdRR5, Ad␣1, Ad␤1, or with both Ad␣1 and Ad␤1 were quantified using enzyme immunoassay (Amersham Life Science). S-Nitrosoglutathione (GSNO, 25 mol/L) or 1H- [1, 2, 4] oxodiazolo [4,3-a] quinoxalin-1-one (ODQ 10 mol/L) (Sigma) was added to selected wells to activate or inhibit sGC activity, respectively. A nonselective phosphodiesterase inhibitor, 3-isobutyl-1-methyl-xanthine (IBMX, 0.3 mmol/L, Sigma), was added to inhibit cGMP degradation.
DNA synthesis in early-passage adenovirus-infected or control RASMCs was measured using [ 3 H]thymidine incorporation in the presence or absence of GSNO (5 mol/L) or 8-bromo-cGMP (8-Br-cGMP, 1 mmol/L) (Sigma).
Migration of early-passage RASMCs that were uninfected or adenovirus-infected was measured in a Transwell migration chamber (Corning) in the presence or absence of GSNO (10 mol/L) and ODQ (1 mol/L). SMC migratory activity, expressed as the mean number of migrating cells, was compared in virus-infected and uninfected cells. Endogenous sGC ␣ 1 and sGC ␤ 1 subunit expression in the vessel wall 1, 2, 4, and 7 days after balloon injury was examined on cryostat sections (5 m) using specific anti-sGC subunit antisera. Expression of sGC ␣ 1 and sGC ␤ 1 subunits was also detected in extracts from 6 balloon-injured arteries using immunoblotting. Levels of immunoreactive subunits 4 days after injury were quantitatively assessed using densitometry of scanned immunoblots.
AdRR5 (1.2ϫ10 10 plaque-forming units [pfu] ) or the combination of Ad␣1 (6ϫ10 9 pfu) and Ad␤1 (6ϫ10 9 pfu) was instilled into a 1.0-cm isolated balloon-injured segment of the rat distal common carotid artery for 20 minutes. Recombinant sGC ␣ 1 and ␤ 1 subunit expression in balloon-injured and Ad␣1-and Ad␤1-infected arteries was detected using specific anti-subunit antisera and anti-FLAG and anti-c-myc antibodies. The distribution of transgene expression after coinfection with Ad␣1 and AdLacZ was examined on the same and on adjacent 5-m sections stained with anti-␣ 1 subunit antiserum and a histochemical stain for ␤-galactosidase.
Four days after balloon injury and gene transfer, biological activity of recombinant sGC ␣ 1 and ␤ 1 subunits was determined by measuring cGMP levels in extracts of balloon-injured carotid arteries from rats coinfected with Ad␣1 and Ad␤1 or with AdRR5 and treated with or without molsidomine (5 mg/kg IP).
Effect of Ad␣1 and Ad␤1 Coinfection on Neointima Formation in Balloon-Injured Rat Carotid Arteries
Neointima formation after balloon injury was compared in rats infected with Ad␣1 and Ad␤1 (nϭ9) or with AdRR5 (nϭ9) in the presence or absence of molsidomine (5 mg/kg twice daily by gavage) and in uninfected rats treated with saline (nϭ6) or molsidomine (nϭ6). After 14 days, morphometric analysis was performed on 5-m paraffin sections, and mean vessel area, intima/media (I/M) ratio, and neointima/vessel area ratio were calculated.
Statistical Methods
All values are expressed as meanϮSEM. Groups were compared by an unpaired Student t test. Differences between multiple groups were isolated by ANOVA, with a Tukey correction. Statistical significance was defined as PϽ0.05.
An expanded Materials and Methods section can be found in an online data supplement available at http://www.circresaha.org.
Results
Vascular sGC Levels After Balloon Injury
To evaluate the effect of balloon injury on sGC expression in rat carotid arteries, sections from injured vessel segments were stained with specific antisera directed against sGC ␣ 1 and ␤ 1 subunits ( Figure 1A ). In medial SMCs, sGC subunit immunoreactivity was markedly less in carotid arteries at 2 to 4 days after injury than in uninjured arteries. After 7 days, sGC subunit levels increased in medial cells and to a lesser extent in neointimal cells. Decreased sGC ␣ 1 subunit expression at 2 and 4 days after injury was confirmed using immunoblotting ( Figure 1B ). Densitometric analysis of scanned immunoblots prepared from extracts of 6 ballooninjured arteries indicated that 4 days after injury, levels of immunoreactive ␣ 1 and ␤ 1 subunit were reduced by 50% and 40%, respectively.
Adenovirus-Mediated sGC ␣ 1 and ␤ 1 Subunit Gene Transfer In Vitro
To determine sGC subunit gene transfer efficiency in cultured cells, RASMCs (passages 9 to 12) were infected with either Ad␣1 or Ad␤1 (nϭ5 each). The efficiency of transduction was high (61Ϯ2% and 70Ϯ2% positive cells, respectively), and no recombinant ␤ 1 subunit immunoreactivity was observed in Ad␣1-infected cells or vice versa. Recombinant sGC subunit immunoreactivity was not detected in untransduced cells, because sGC subunit expression is markedly reduced in repeatedly passaged RASMCs (unpublished observations). The percentage of cells expressing recombinant protein after coinfection with Ad␣1 and Ad␤1 (62Ϯ3% ␣ 1 subunit-positive RASMCs and 72Ϯ1% ␤ 1 subunit-positive RASMCs) was similar to the percentage of transduced cells after infection with a single virus.
To confirm biological activity of the expressed transgenes, cGMP levels were measured in RASMCs after sGC subunit gene transfer. cGMP concentrations were modestly higher in RASMCs coinfected with Ad␣1 and Ad␤1 than in AdRR5-infected cells (2.6Ϯ0.4 versus 1.2Ϯ0.1 pmol/mg protein, PϽ0.05, nϭ4 each) (Figure 2 ). Infection with either Ad␣1 or Ad␤1 alone did not increase cGMP levels (1.2Ϯ0.4 and 1.2Ϯ0.2 pmol/mg protein, respectively, nϭ4 each). Exposure to the NO donor GSNO caused a 9-fold greater increase in cGMP levels in cells coinfected with Ad␣1 and Ad␤1 than in AdRR5-infected cells and was inhibited by ODQ (10 mol/L), a specific sGC inhibitor (Figure 2 ). These results suggest that coinfection of RASMCs with Ad␣1 and Ad␤1 increases NO-stimulated sGC activity.
To determine the effect of sGC subunit gene transfer on RASMC DNA synthesis, [ 3 H]thymidine incorporation in RASMCs coinfected with Ad␣1 and Ad␤1 was compared with that in uninfected and AdGFP-infected RASMCs.
[ 3 H]Thymidine uptake at baseline and in the presence of 5 mol/L GSNO was 9% and 16%, respectively, less in RASMCs coinfected with Ad␣1 and Ad␤1 than in AdGFPinfected cells (PϽ0.05 for both, Figure 3 ). The decrease in DNA synthesis observed in Ad␣1-and Ad␤1-coinfected RASMCs was similar to that observed in uninfected RASMCs incubated with 8-Br-cGMP (1 mmol/L). These results indicate that coinfection with Ad␣1 and Ad␤1 decreases RASMC DNA synthesis in vitro.
To determine whether increased sGC gene function could reduce RASMC migration, adenovirus-infected and uninfected RASMCs were transferred to a Transwell migration chamber. The number of migrating RASMCs was 34% less Figure 1 . A, Endogenous sGC ␣ 1 and ␤ 1 subunit immunoreactivity in uninjured and balloon-injured rat carotid arteries. Diffuse sGC ␣ 1 and ␤ 1 subunit immunoreactivity was observed in medial SMCs of an uninjured control artery. sGC subunit immunoreactivity was markedly less in medial SMCs at 2 to 4 days after injury than in medial SMCs in uninjured arteries. After 7 days, sGC subunit levels were once again detected in medial cells and to a lesser extent in neointimal cells. B, Expression of sGC ␣ 1 subunit in uninjured arteries and in arteries 2 or 4 days after balloon injury. Extracts were analyzed for sGC ␣ 1 subunit levels by Western blotting using an anti-sGC ␣ 1 subunit antibody. Actin immunoreactivity is presented for comparison. 
Adenovirus-Mediated sGC ␣ 1 and ␤ 1 Subunit Gene Transfer In Vivo
To evaluate vascular sGC gene transfer efficiency and distribution in the injured vessel wall, transgene expression was studied 4 days after Ad␣1 and Ad␤1 gene transfer using specific antisera against epitope tags on recombinant sGC subunits. Staining of adjacent 5-m sections of the vessel wall coinfected with Ad␣1 and Ad␤1 indicated that anti-FLAG and anti-c-myc immunoreactivities were not randomly distributed but rather colocalized to discrete regions of the vessel wall ( Figure 5 ). These results were confirmed in rat carotid arteries after coinfection with Ad␣1 and AdLacZ, wherein nuclear localization of ␤-galactosidase coincided with cytoplasmic expression of recombinant sGC ␣ 1 subunit both in the same and in adjacent sections ( Figure 5 ). To confirm that sGC gene transfer restores NO responsiveness in the injured vessel wall, vascular cGMP concentrations were measured 4 days after injury with or without sGC subunit gene transfer. Balloon injury with subsequent loss of endothelium-derived NO production reduces baseline cGMP levels from 0.26Ϯ0.02 pmol cGMP/mg protein in uninjured vessels (nϭ5) to 0.12Ϯ0.02 and 0.10Ϯ0.03 pmol cGMP/mg protein in AdRR5-infected vessels (nϭ5) and in vessels coinfected with Ad␣1 and Ad␤1 (nϭ5), respectively (PϽ0.05) (Figure 6 ). Molsidomine increased cGMP levels in uninjured arteries (1.22Ϯ0.41 pmol/mg protein, PϽ0.05 versus no molsidomine, nϭ6) and in injured arteries coinfected with Ad␣1 and Ad␤1 (0.53Ϯ0.09 pmol/mg protein PϽ0.05 
Neointima Formation in Ad␣1-and Ad␤1-Coinfected Balloon-Injured Rat Carotid Arteries
To determine whether sGC gene transfer decreases neointima formation after balloon injury, histomorphometric analysis was performed on sections from rat carotid arteries 14 days after injury and gene delivery with or without molsidomine treatment. In the absence of an NO donor, neointima formation, assessed by the I/M ratio, was similar in AdRR5-infected carotid arteries and in arteries coinfected with Ad␣1 and Ad␤1 (0.97Ϯ0.21 versus 0.91Ϯ0.17, PϭNS, nϭ6 and nϭ7, respectively) ( Figure 7) . When rats were treated with molsidomine, I/M ratio was significantly less in arteries coinfected with Ad␣1 and Ad␤1 than in AdRR5-infected arteries (0.36Ϯ0.11 versus 0.81Ϯ0.13, nϭ9 and nϭ7, respectively, PϽ0.05) (Figures 7 and 8) . Administration of molsidomine alone did not reduce I/M ratio in uninfected balloon-injured arteries (0.75Ϯ0.25 versus 0.67Ϯ0.22 without molsidomine, respectively, nϭ12). Total vessel area was similar in AdRR5-infected arteries and in arteries coinfected with Ad␣1 and Ad␤1 (0.41Ϯ0.01 versus 0.42Ϯ0.03 mm 2 , respectively, PϭNS) and was not affected by molsidomine (0.43Ϯ0.03 versus 0.47Ϯ0.03 mm 2 , respectively, PϭNS), indicating that molsidomine did not affect arterial remodeling. Details of the morphometric analysis are provided in Table 1 online, which is available in the online data supplement (see http://www.circresaha.org). Taken together, these results suggest that overexpression of sGC ␣ 1 and ␤ 1 subunits reduces neointima formation after balloon injury in the presence of a low dose of an NO donor.
Discussion
Balloon injury of rat carotid arteries modulates the expression and function of components of the NO/cGMP signal transduction system. In the present study, a marked reduction in the expression of a critical NO receptor, sGC, was observed in rat carotid arteries after balloon injury. This resulted in decreased vascular cGMP production in response to the NO donor molsidomine. Adenovirus-mediated transfer of the genes encoding the 2 sGC subunits into injured carotid arteries resulted in coexpression of sGC ␣ 1 and ␤ 1 subunits in segments of the vessel wall, illustrating the "nonrandom" nature of in vivo adenovirus infection. In addition, transduction with sGC ␣ 1 and ␤ 1 subunits enhanced NO responsiveness of the injured vessel wall as reflected by increased tissue cGMP concentrations and reduced neointima formation in the presence of low concentrations of molsidomine.
Immunohistochemical and functional evidence of decreased sGC expression in medial SMCs was evident during the first week after balloon injury. This decrease in sGC function for at least 4 days after injury may reduce the ability of the injured blood vessel to respond to the inhibitory effects of endogenous and exogenous NO on neointima formation. Figure 6 . Vascular cGMP concentrations measured in uninjured left carotid arteries (nϭ7) and 4 days after balloon injury in right carotid arteries coinfected with Ad␣1 and Ad␤1 (nϭ5) or infected with AdRR5 (nϭ5). Compared with uninjured vessels, cGMP levels were decreased in injured vessels (*PϽ0.05). Administration of NO donor molsidomine (5 mg/kg IP) increased cGMP levels in uninjured arteries (nϭ7, †PϽ0.05 vs without molsidomine) and in injured arteries coinfected with Ad␣1 and Ad␤1 (nϭ6, †PϽ0.05 vs without molsidomine) but not in AdRR5-infected arteries (nϭ4). After administration of molsidomine, cGMP levels were higher in injured arteries coinfected with Ad␣1 and Ad␤1 than in AdRR5-infected arteries ( ‡PϽ0.05). Figure 7 . Neointima formation after balloon injury in uninfected and AdRR5-infected or Ad␣1-and Ad␤1-coinfected carotid arteries. Mean I/M ratio was comparable in uninfected carotid arteries (nϭ6) and infected arteries 2 weeks after balloon injury (nϭ7 for AdRR5, nϭ6 for Ad␣1 and Ad␤1). In contrast, in animals treated with molsidomine (5 mg/kg BID) for 14 days, mean I/M ratio was less in carotid arteries coinfected with Ad␣1 and Ad␤1 (nϭ9) than in uninfected or in AdRR5-infected arteries (nϭ6 and nϭ7, respectively; *PϽ0.05 for both). 
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The findings that balloon injury decreased the ability of molsidomine to increase carotid artery cGMP levels 5-fold but only decreased sGC subunit protein levels 2-fold suggest that additional mechanisms contribute to the decreased cGMP levels in NO-exposed balloon-injured rat carotid arteries. They include possible injury-induced increases in cGMPmetabolizing phosphodiesterase activity or decrease in sGC enzyme-specific activity. Similar downregulation of sGC and loss of NO responsiveness has recently been demonstrated in hypertensive 22 or aging 23 rats. Decreased expression of sGC ␤ 1 subunit prevented NO-mediated inhibition of DNA synthesis in SMCs from aging rats. 23 In our study, adenovirusmediated transfer of the genes encoding sGC ␣ 1 and ␤ 1 subunits increased sGC function and significantly reduced neointima formation in the presence of a low concentration of the NO donor molsidomine. This low dose of molsidomine by itself did not affect the vascular response to injury. Daily administration of molsidomine, even at doses 2-to 20-fold higher than those used here, failed to reduce neointima formation in rabbit carotid arteries injured by placement of a collar, 24 in rat carotid arteries injured by air drying, 25 and in porcine coronary arteries subjected to balloon angioplasty. 26 The failure of molsidomine to affect the response to injury in all of these models may be caused by insufficient local NO concentrations at the site of injury or by decreased NO responsiveness of target vascular cells. Vascular genetransfer strategies aimed at restoring NO responsiveness or increasing local NO production without prohibitive hypotensive side effects would be anticipated to reduce the neointimal response to vascular injury. The precise mechanisms whereby high local NO concentrations reduce the vascular response to injury are unknown but could involve cGMP-dependent or cGMP-independent effects on vascular cells. It is also unknown whether or not the effects of NO on vascular cell functions in vitro reflect events occurring in vivo. Our findings with sGC subunit gene transfer in combination with low-dose molsidomine treatment suggest that increasing sGC activity decreases vascular SMC functions contributing to neointima formation. Inhibition of neointima formation by NO is likely due, at least in part, to direct cGMP-dependent antiproliferative and antimigratory effects on SMCs in the vessel wall.
Increased sGC expression and NO responsiveness did not completely prevent neointima formation. This could be related to an insufficient percentage of transduced cells in the injured vessel wall or to transient transgene expression, characteristic of gene transfer with first-generation adenoviral vectors. Alternatively, downstream components of the NO/ cGMP signal transduction system may be impaired in response to vascular injury. Expression of one of the intracellular targets of cGMP, cGMP-dependent protein kinase (PKG), was found to be downregulated after balloon injury in porcine and human coronary arteries, 27 although this was not confirmed by others. 28 Although denudation of the endothelium removes NO production by NOS3, it has been reported that the inducible NOS isoform, NOS2, is expressed in SMCs after vascular injury. 29, 30 However, in our studies, cGMP levels were not increased in arteries 4 days after infection with Ad␣1 and Ad␤1 in the absence of molsidomine. In contrast, cGMP levels were increased in cultured RASMCs coinfected with Ad␣1 and Ad␤1. This discrepancy may be explained by the higher efficiency of gene transduction and/or the addition of a phosphodiesterase inhibitor in the in vitro experiments. Similarly, overexpression of both sGC subunits did not decrease neointima formation in the absence of an exogenous NO donor. This suggests that, after vascular injury, there is insufficient endogenous NO production to activate the recombinant sGC subunits and impact neointima formation. NO production by NOS2 does not appear sufficient to limit neointimal formation, given that mice that lack the NOS2 gene 31 have less neointima formation after vascular injury. NOS2 may contribute to neointima formation by producing superoxide radicals, which also may inactivate sGC through oxidation of the heme group. 32 Coinfection of cultured RASMCs with Ad␣1 and Ad␤1 reduced DNA synthesis and migration. The disparity between the large NO-stimulated rise in intracellular cGMP levels and the moderate inhibition of DNA synthesis and migration in vascular SMCs coinfected with Ad␣1 and Ad␤1 may be accounted for, in part, by the absence of a phosphodiesterase inhibitor in assays of cell function in vitro. Another possible explanation is that PKG is reduced in passaged vascular SMCs. 33 Restoration of PKG activity in vascular SMCs via adenovirus-mediated gene transfer increased the sensitivity of these cells to the antiproliferative and proapoptotic effects of NO/cGMP. 34 Thus, the observed moderate reduction in DNA synthesis and migration in this study are in part due to limitations of studying vascular SMCs in culture.
Immunohistochemical studies revealed the unexpected finding that, in carotid arteries infected with 2 different adenoviral vectors, the expression of recombinant sGC ␣ 1 and ␤ 1 subunits or of sGC ␣ 1 subunit and LacZ was confined to similar regions in the injured vessel wall. Coexpression of both sGC subunits in vascular cells is required for the function of the intracellular and heterodimeric sGC. This observation suggests that vascular gene transfer is a nonrandom event, possibly preferentially occurring in areas of injury characterized by rupture of the internal elastic lamina. 35 Although not evident in our light microscopic study, there may have been areas of internal elastic lamina damage at an ultrastructural level, which may favor focal gene transfer. Balloon manipulation may variably affect different regions of the vessel segment potentially altering the infectivity or the ability of vascular cells to express the transgene. Alternatively, differences in infectivity may be caused by variable adenovirus receptor expression in cells along the injured vessel segment. Finally, it is possible that infection of vascular cells with one adenoviral vector may facilitate infectivity of a second adenoviral vector. The efficacy of simultaneous administration of distinct adenoviral vectors to target similar regions in the vessel wall provides an opportunity for innovative vascular gene transfer protocols.
In summary, local adenovirus-mediated gene transfer of sGC ␣ 1 and ␤ 1 subunits partially restored sGC function and NO responsiveness in balloon-injured rat carotid arteries resulting in reduced neointima formation in the presence of a low concentration of an NO donor. These results suggest that NO can reduce neointima formation, at least in part, by increasing intracellular cGMP levels in vascular SMCs, thereby reducing their proliferative and migratory index.
